Search results
Laurie H. Glimcher, MD. Dr. Laurie H. Glimcher is the president and chief executive officer of the Dana-Farber Cancer Institute, and also serves on the National Cancer Moonshot Blue Ribbon Panel. Dr. Glimcher first achieved renown for her discoveries involving the differentiation of T cells, especially CD4+ T cells, which earned her the 2012 ...
Laurie Glimcher learned early on from her father, a prominent physician-researcher, that success in science was built on a basic principle: Big discoveries require big risks. The younger Glimcher ...
Laurie Glimcher. As CEO of the Dana-Farber Cancer Institute, Laurie Glimcher isn’t afraid to shake things up. She made big waves last year when the institute announced that it was ending its 30 ...
Nov 2, 2006 · Her father, Melvin Glimcher, who chaired MGH’s Orthopedics Department at the time, nourished not only bone cells in that lab, but also his middle daughter’s passion for science. Today, Laurie and Melvin Glimcher are something of a rarity at Harvard: a father-daughter pair who both hold named chairs in their respective fields and who carry ...
Apr 10, 2024 · Laurie Hollis Glimcher (born 1951) is an American physician-scientist who was appointed president and CEO of Dana–Farber Cancer Institute in October 2016. She was elected a Member of the American Philosophical Society in 2019.
May 31, 2014 · Dr. Laurie Glimcher, who confirmed the death, said her father had a restless curiosity and energy well into his later years, and would sleep only four hours a night. Four months before giving a ...
Jul 21, 2017 · Dr Glimcher recently decided to step down from the Board of Bristol-Myers Squibb Co (BMS) after serving for 20 years on its Board. Dr Glimcher has recently been awarded the Kober Medal from the American Association of Physicians for a lifetime of achievements in the field of internal medicine.
